Document is current
Any future updates will be listed below
-
Authors
Mims, Alice S. https://orcid.org/0000-0002-8971-2199
Kohlschmidt, Jessica
Borate, Uma
Blachly, James S.
Orwick, Shelley
Eisfeld, Ann-Kathrin
Papaioannou, Dimitrios
Nicolet, Deedra
Mrá½¹zek, Krzysztof
Stein, Eytan
Bhatnagar, Bhavana
Stone, Richard M.
Kolitz, Jonathan E.
Wang, Eunice S.
Powell, Bayard L.
Burd, Amy
Levine, Ross L.
Druker, Brian J.
Bloomfield, Clara D.
Byrd, John C.
-
Funding
Funding for this research was provided by:
National Cancer Institute (U10CA180821, U10CA180882)
- License Information
-
More Information
Article History
Received: 5 April 2021
Accepted: 4 June 2021
First Online: 23 June 2021
Declarations
:
: Patients provided written informed consent to participate in companion protocols CALGB 8461 (cytogenetic studies), CALGB 9665 (leukemia tissue bank), and CALGB 20202 (molecular studies), which involved collection of pretreatment BM and blood samples. Treatment protocols were in accordance with the Declaration of Helsinki and approved by the institutional review boards at each center participating in the CALGB/Alliance treatment protocols, and all patients provided written informed consent.
: Not applicable.
: The authors declare no conflicts of or competing interest.
